市場調查報告書

幹細胞的全球市場:成長率,趨勢及預測(2019年∼2024年)

Stem Cell Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 390704
出版日期 內容資訊 英文 112 Pages
商品交期: 2-3個工作天內
價格
Back to Top
幹細胞的全球市場:成長率,趨勢及預測(2019年∼2024年) Stem Cell Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年03月01日內容資訊: 英文 112 Pages
簡介

由於全球臨床試驗增加,幹細胞市場成長著。北美地區,尤其是美國,接受幹細胞療法的實驗數處於優勢。美國,在產品及銀行服務兩個市場區隔中支配市場,佔北美市場整體約77.4%。另一方面,亞太地區以最高成長率成長。幹細胞主要用於在再生醫療,尤其是皮膚科的領域。還有腫瘤學,由於治療腫瘤或癌症而存在的多數開發中產品,預計將以最高的成長率成長。隨著再生醫療中心的增加,預計幹細胞市場未來也將擴大。

本報告提供全球幹細胞市場調查,整體市場趨勢,各產品類型、治療用途、治療類型、銀行服務、技術及銀行類型、地區的詳細趨勢,市場成長的影響要素分析,競爭情形,主要企業簡介等資訊總括性彙整。

目錄

1 簡介

  • 調查的成果
  • 調查的前提條件
  • 調查範圍

2 調查方法

3 摘要整理

4 市場動態

  • 市場概況
  • 市場成長要素
    • 臍帶幹細胞相關的意識高漲
    • 幹細胞研究的臨床試驗的認證增加
    • 對再生治療的選項的需求高漲
    • 為了開發慢性疾病治療選項的研究開發舉措的高漲
  • 市場阻礙因素
    • 高額的治療
    • 法規上的問題
    • 倫理及道德架構
  • 產業的魅力 - 波特的五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 賣主談判力
    • 替代產品的威脅
    • 產業內的競爭激烈度

5 市場區隔

  • 各產品類型
    • 成人幹細胞
    • 人類胚胎細胞
    • 多功能幹細胞
    • 其他產品類型
  • 各治療用途
    • 神經學的障礙
    • 整形外科治療
    • 腫瘤疾病
    • 糖尿病
    • 傷和傷
    • 心血管障礙
    • 其他治療用途
  • 各治療類型
    • 同類幹細胞療法
    • 自動邏輯幹細胞療法
    • 同基因幹細胞療法
  • 銀行服務及各技術
    • 幹細胞的取得與檢查
    • 細胞生成
    • 擴張
    • 二次培養
    • 凍結保存
  • 各銀行類型
    • 公共
    • 民間
  • 地理
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

6 競爭情形

  • 企業簡介
    • Osiris Therapeutics Inc.
    • Pluristem Therapeutics Inc.
    • Thermo Fisher Scientific
    • Qiagen NV
    • Sigma Aldrich Corporation
    • Becton, Dickinson and Company
    • Stem Cell Technologies Inc.
    • AllCells LLC
    • Miltenyi Biotec
    • International Stem Cell Corporation

7 市場機會及未來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 47511

Market Overview

The stem cell market is experiencing growth, owing to the increasing number of clinical trials around the world. North America, especially the United States, dominated the number of trials undergoing in stem cell therapies. The United States dominates the market in both the products and banking services segments, holding around 77.4% of the total North American market. However, Asia-Pacific is growing at the highest growth rate. Stem cells are majorly used in regenerative medicine, especially in the field of dermatology. However, oncology is expected to grow at the highest growth rate, due to a large number of pipeline products present for the treatment of tumors or cancers. With the increase in the number of regenerative medicine centers, the stem cell market is also expected to increase in the future.

Stem cells banking is gaining importance with the support of government initiatives. The number of stem cell banks is increasing in developing countries, which is aiding the growth of the market. Also, increasing awareness about stem cell storage among the people has positively affected the market. Currently, the market is not well established in many therapeutic areas and has shown nascent success in history. However, it holds great potential in both the diagnosis and therapeutic fields.

Scope of the Report

The scope of this market is limited to tracking the stem cell market. As per the scope of this report, stem cells are biological cells that can differentiate into other types of cells. Also, various types of stem cells are used for therapeutic purposes.

Key Market Trends

Oncology Disorders Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period

Cancer has a major impact on society in the United States and across the world. As per the estimation of National Cancer Institute, in 2018, 1,735,350 new cases of cancer were anticipated to get diagnosed in the United States, and 609,640 deaths were expected from the disease. This increasing medical burden is due to population growth. Bone marrow transplant or stem cell transplant is a treatment for some types of cancers, like leukemia, multiple myeloma, multiple myeloma, neuroblastoma, or some types of lymphoma.

Embryonic stem cells (ESC) are the major source of stem cells for therapeutic purposes, due to their higher totipotency and indefinite lifespan, as compared to adult stem cells with lower totipotency and restricted lifespan. However, the use of ESCs for research and therapeutic purposes is restricted and prohibited in many countries throughout the world, due to some ethical constraints. Scientists from the University of California, Irvine, created the stem cell-based approach to kill cancerous tissue while preventing some toxic side effects of chemotherapy by treating the disease in a more localized way.

Although the market shows positive growth, due to the growing focus of stem cell-based research that can further strengthen the clinical application, its expensive nature for stem cell therapy may still hamper its growth.

North America Captured The Largest Market Share and is Expected to Retain its Dominance

North America dominated the overall stem cell market with the United States contributing to the largest share in the market. In 2014, the Sanford Stem Cell Clinical Center at the University of California, San Diego (UCSD) Health System, announced the launch of a clinical trial, in order to assess the safety of neural stem cell-based therapy in patients with chronic spinal cord injury. Researchers hoped that the transplanted stem cells may develop into new neurons that could replace severed or lost nerve connections, and restore at least some motor and sensory functions. Such numerous stem cell studies across the United States have helped in the growth of the stem cell market.

Competitive Landscape

The stem cell market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. The presence of major market players, such as Thermo Fisher Scientific, Qiagen NV, Sigma Aldrich (A Subsidiary of Merck KGaA), Becton, Dickinson and Company, and Stem Cell Technologies, is in turn, increasing the overall competitive rivalry in the market. The product advancements and improvement in stem cell technology by the major players are increasing the competitive rivalry.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increased Awareness about Umbilical Stem Cell
    • 4.2.2 Increase in the Approval for Clinical Trials in Stem Cell Research
    • 4.2.3 Growing Demand for Regenerative Treatment Option
    • 4.2.4 Rising R&D Initiatives to Develop Therapeutic Options for Chronic Diseases
  • 4.3 Market Restraints
    • 4.3.1 Expensive Procedures
    • 4.3.2 Regulatory Complications
    • 4.3.3 Ethical and Moral Framework
  • 4.4 Industry Attractiveness- Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Adult Stem Cell
    • 5.1.2 Human Embryonic Cell
    • 5.1.3 Pluripotent Stem Cell
    • 5.1.4 Other Product Types
  • 5.2 By Therapeutic Application
    • 5.2.1 Neurological Disorders
    • 5.2.2 Orthopedic Treatments
    • 5.2.3 Oncology Disorders
    • 5.2.4 Diabetes
    • 5.2.5 Injuries and Wounds
    • 5.2.6 Cardiovascular Disorders
    • 5.2.7 Other Therapeutic Applications
  • 5.3 By Treatment Type
    • 5.3.1 Allogeneic Stem Cell Therapy
    • 5.3.2 Auto logic Stem Cell Therapy
    • 5.3.3 Syngeneic Stem Cell Therapy
  • 5.4 By Banking Service and Technology
    • 5.4.1 Stem Cell Acquisition and Testing
    • 5.4.2 Cell Production
    • 5.4.3 Expansion
    • 5.4.4 Sub-culture
    • 5.4.5 Cryopreservation
  • 5.5 By Type of Banking
    • 5.5.1 Public
    • 5.5.2 Private
  • 5.6 Geography
    • 5.6.1 North America
      • 5.6.1.1 US
      • 5.6.1.2 Canada
      • 5.6.1.3 Mexico
    • 5.6.2 Europe
      • 5.6.2.1 UK
      • 5.6.2.2 Germany
      • 5.6.2.3 France
      • 5.6.2.4 Italy
      • 5.6.2.5 Spain
      • 5.6.2.6 Rest of Europe
    • 5.6.3 Asia-Pacific
      • 5.6.3.1 China
      • 5.6.3.2 Japan
      • 5.6.3.3 India
      • 5.6.3.4 Australia
      • 5.6.3.5 South Korea
      • 5.6.3.6 Rest of Asia-Pacific
    • 5.6.4 Middle East & Africa
      • 5.6.4.1 GCC
      • 5.6.4.2 South Africa
      • 5.6.4.3 Rest of Middle East & Africa
    • 5.6.5 South America
      • 5.6.5.1 Brazil
      • 5.6.5.2 Argentina
      • 5.6.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Osiris Therapeutics Inc.
    • 6.1.2 Pluristem Therapeutics Inc.
    • 6.1.3 Thermo Fisher Scientific
    • 6.1.4 Qiagen NV
    • 6.1.5 Sigma Aldrich Corporation
    • 6.1.6 Becton, Dickinson and Company
    • 6.1.7 Stem Cell Technologies Inc.
    • 6.1.8 AllCells LLC
    • 6.1.9 Miltenyi Biotec
    • 6.1.10 International Stem Cell Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top